#4 Ross O. Youngs - Founder and CEO of Biosortia Pharmaceuticals

Through an interesting turn of events Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities they are able to extrapolate this into drug discovery. Ross believes that Biosortias ability to mine microbiome on such a large scale will change drug discovery in the coming years. Support the showCheck me out on LinkedIn https://www.linkedin.com/in/ammonr/